The size of the Blood Pressure Monitoring Device Market in the Asia Pacific was worth USD 605.81 Million in 2022 and is estimated to be growing at a CAGR of 8.64%, to reach USD 916.82 Million by 2027.
Blood pressure monitoring devices are projected to become more prevalent, as they can help with the early detection of a patient's deteriorating health status. Furthermore, modern blood pressure monitoring devices are developed for personal use and can track a patient's health state remotely. The demand for Asia pacific blood pressure monitoring devices is predicted to rise globally, owing to an increase in the frequency of chronic diseases, rising healthcare expenditures in emerging economies, a strong need for proactive monitoring, and a quick expansion in the senior population. Devices that use sensors and computerized mathematical modeling for pulse recording are among the most modern technologies.
Compared to traditional equipment, technologically improved products are far more comfortable and simpler to use. Bluetooth-enabled devices and finger blood pressure monitors are two other advanced technologies propelling the business forward. Over the forecast period, the hypertension monitoring devices market will be driven by rising government initiatives to minimize mortality caused by hypertension and increasing demand for portable equipment.
High costs for technological developments may hamper the blood pressure monitoring devices market in the APAC region, a scarcity of educated physicians, and a lack of awareness. Doctors are increasingly advocating home blood pressure monitoring for patients with severe hypertension. Patients with hypertension can better control their clinical condition by having regular check-ups at home. However, the inaccuracy of the results produced by they might hamper demand.
This research report of the blood pressure monitoring devices market in the APAC has been segmented and sub-segmented into the following categories:
Asia is one of the world's highly populated countries and has emerged as an epicenter of COPD, diabetes, and diseases epidemics. Due to the presence of untapped potential, increased manufacturer investments, rising awareness levels, and rising hypertension incidences, Asia Pacific is predicted to develop at a quick rate over the projection period. The rapid improvement of healthcare facilities and the rising number of undiagnosed and untreated instances of high blood pressure are driving regional market expansion. High blood pressure is a significant cause of several diseases such as heart attack, stroke, and renal failure; thus, blood pressure monitoring is essential to determine the severity of a patient's condition. The increase in the adoption of blood pressure monitoring devices is due to the rise in cardiovascular diseases such as the risk of high BP in the geriatric population and expanding base of lifestyle diseases, including obesity and diabetes. Government measures to raise public awareness and a constantly growing number of people with target diseases are all contributing to the lucrative expansion of the market in this region. For example, in May 2018, the Indian Council of Medical Research (ICMR) launched a "May Measurement Month 2018" campaign in partnership with the Public Health Foundation of India to raise awareness about blood pressure, which is India's leading cause mortality and morbidity.
KEY MARKET PLAYERS:
Companies playing a promising role in the APAC Blood Pressure Monitoring Device Market profiled in this report are GE Healthcare, Welch Allyn, A&D Medical Inc., SunTech Medical, Rossmax International Ltd, Spacelabs Healthcare Inc. Panasonic Corporation, Philips Healthcare, Contec Medical Systems Co. Ltd, Omron Healthcare, and Microlife AG.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com